Grigorios Siokas Purchases 168,472 Shares of Cosmos Health (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas acquired 168,472 shares of the firm’s stock in a transaction on Monday, December 15th. The stock was purchased at an average price of $0.42 per share, with a total value of $70,758.24. Following the purchase, the chief executive officer owned 6,628,457 shares in the company, valued at approximately $2,783,951.94. The trade was a 2.61% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Grigorios Siokas also recently made the following trade(s):

• On Friday, November 28th, Grigorios Siokas bought 76,360 shares of Cosmos Health stock. The stock was acquired at an average price of $0.64 per share, for a total transaction of $48,870.40.
• On Tuesday, November 25th, Grigorios Siokas bought 55,732 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.63 per share, with a total value of $35,111.16.
• On Friday, November 21st, Grigorios Siokas purchased 56,080 shares of Cosmos Health stock. The shares were acquired at an average price of $0.68 per share, for a total transaction of $38,134.40.
• On Thursday, November 20th, Grigorios Siokas acquired 51,315 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.62 per share, for a total transaction of $31,815.30.
• On Wednesday, November 19th, Grigorios Siokas acquired 61,614 shares of Cosmos Health stock. The stock was acquired at an average price of $0.65 per share, with a total value of $40,049.10.

Cosmos Health Stock Performance

Shares of NASDAQ:COSM traded up $0.06 during midday trading on Tuesday, reaching $0.48. The company had a trading volume of 834,726 shares, compared to its average volume of 619,247. Cosmos Health Inc. has a 52-week low of $0.28 and a 52-week high of $1.32. The company’s 50 day moving average price is $0.77 and its 200 day moving average price is $0.72. The company has a current ratio of 0.99, a quick ratio of 0.84 and a debt-to-equity ratio of 0.25. The stock has a market cap of $16.73 million, a P/E ratio of -0.64 and a beta of 5.34.

Cosmos Health (NASDAQ:COSM) last issued its quarterly earnings results on Friday, November 14th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.16). Cosmos Health had a negative return on equity of 33.19% and a negative net margin of 31.01%.The company had revenue of $17.11 million for the quarter, compared to analysts’ expectations of $16.40 million. As a group, sell-side analysts anticipate that Cosmos Health Inc. will post -0.78 EPS for the current fiscal year.

Wall Street Analyst Weigh In

COSM has been the subject of several research reports. Wall Street Zen upgraded Cosmos Health to a “hold” rating in a research note on Saturday, September 20th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Cosmos Health in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has an average rating of “Sell”.

Institutional Trading of Cosmos Health

A hedge fund recently raised its stake in Cosmos Health stock. Armistice Capital LLC boosted its stake in Cosmos Health Inc. (NASDAQ:COSM) by 156.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,917,710 shares of the company’s stock after purchasing an additional 1,168,884 shares during the quarter. Armistice Capital LLC owned approximately 7.03% of Cosmos Health worth $836,000 as of its most recent filing with the Securities & Exchange Commission. 12.61% of the stock is owned by institutional investors and hedge funds.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.